Diabetes induces macrophage dysfunction through cytoplasmic dsDNA/AIM2 associated pyroptosis

Area of Science:

• Immunology
• Endocrinology
• Gerontology

Background:

• Diabetes mellitus is a global health crisis with periodontal complications.
• Macrophages are key immune cells in the periodontium, crucial for innate immunity.
• Periodontal impairment is a recognized complication of diabetes.

Purpose of the Study:

• To investigate periodontal impairments and macrophage functional changes in diabetic and aging conditions.
• To explore the molecular mechanisms linking hyperglycemia and aging to periodontal pathogenesis.
• To evaluate the therapeutic potential of metformin in reversing diabetes-induced periodontal damage.

Main Methods:

• Utilized young and aged mice to model diabetic conditions.
• Administered metformin treatment to a subset of diabetic mice.
• Assessed macrophage functions, including cytokine secretion, phagocytosis, and chemotaxis.
• Analyzed the expression of pyroptosis-related markers like Gasdermin D (GSDMD) and caspase-1.
• Evaluated senescent cell burden and senescence-associated secretory phenotype.

Main Results:

• Hyperglycemia disrupted macrophage functions and increased senescent cell burden.
• Elevated GSDMD and caspase-1 expression indicated pyroptosis initiation in diabetic conditions.
• Diabetes-induced changes mimicked aging, suggesting a pre-aging state.
• Metformin treatment significantly alleviated and reversed macrophage dysfunction and periodontal impairments.
• Diabetes initiated macrophage pyroptosis, leading to functional deficits and gingival destruction.

Conclusions:

• Diabetes triggers macrophage pyroptosis, causing functional impairments and periodontal destruction.
• The observed changes resemble an aging phenotype, highlighting a hyperglycemia-induced pre-aging state.
• Metformin demonstrates significant therapeutic potential in reversing diabetes-associated periodontal pathogenesis.